A detailed history of Steele Capital Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Steele Capital Management, Inc. holds 13,614 shares of ABBV stock, worth $2.45 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
13,614
Previous 13,600 0.1%
Holding current value
$2.45 Million
Previous $2.33 Billion 15.26%
% of portfolio
0.14%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$163.84 - $199.33 $2,293 - $2,790
14 Added 0.1%
13,614 $2.69 Billion
Q2 2024

Jul 16, 2024

SELL
$154.79 - $180.76 $3,250 - $3,795
-21 Reduced 0.15%
13,600 $2.33 Billion
Q1 2024

Apr 18, 2024

BUY
$159.82 - $182.1 $57,535 - $65,556
360 Added 2.71%
13,621 $2.48 Billion
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $1.82 Million - $2.06 Million
13,261 New
13,261 $2.06 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Steele Capital Management, Inc. Portfolio

Follow Steele Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steele Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Steele Capital Management, Inc. with notifications on news.